Eileen Teng

554 total citations
10 papers, 448 citations indexed

About

Eileen Teng is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Eileen Teng has authored 10 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Eileen Teng's work include Cell death mechanisms and regulation (2 papers), Pluripotent Stem Cells Research (2 papers) and Fibroblast Growth Factor Research (2 papers). Eileen Teng is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Pluripotent Stem Cells Research (2 papers) and Fibroblast Growth Factor Research (2 papers). Eileen Teng collaborates with scholars based in Singapore, United Kingdom and Thailand. Eileen Teng's co-authors include Shing Leng Chan, Yee‐Joo Tan, Jimmy Bok Yan So, Wen Min Lau, Asim Shabbir, Manuel Salto‐Tellez, Hui Shan Chong, Eng Eong Ooi, Wanjin Hong and Timothy H. P. Tan and has published in prestigious journals such as Blood, Cancer Research and Journal of Virology.

In The Last Decade

Eileen Teng

10 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Teng Singapore 7 252 123 100 68 62 10 448
Andrea Franconi France 5 421 1.7× 136 1.1× 44 0.4× 20 0.3× 108 1.7× 7 693
Mirco Compagnone Italy 13 296 1.2× 234 1.9× 44 0.4× 37 0.5× 56 0.9× 23 479
Hua Cao China 16 366 1.5× 115 0.9× 37 0.4× 20 0.3× 137 2.2× 39 524
Rémy Poirey Germany 13 172 0.7× 289 2.3× 65 0.7× 25 0.4× 71 1.1× 20 467
Rajeev K. Boregowda United States 9 203 0.8× 61 0.5× 56 0.6× 25 0.4× 60 1.0× 14 407
Jennifer Schöning Germany 9 262 1.0× 102 0.8× 31 0.3× 16 0.2× 198 3.2× 11 464
Mary‐Ann Lane United States 10 286 1.1× 151 1.2× 20 0.2× 12 0.2× 59 1.0× 17 551
Cheryl A. Carlson United States 16 376 1.5× 291 2.4× 61 0.6× 7 0.1× 38 0.6× 23 710
Bo Luan United States 7 251 1.0× 302 2.5× 76 0.8× 12 0.2× 49 0.8× 8 540
Ta-Jen Liu United States 7 490 1.9× 353 2.9× 36 0.4× 19 0.3× 30 0.5× 8 687

Countries citing papers authored by Eileen Teng

Since Specialization
Citations

This map shows the geographic impact of Eileen Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Teng more than expected).

Fields of papers citing papers by Eileen Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Teng. The network helps show where Eileen Teng may publish in the future.

Co-authorship network of co-authors of Eileen Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Teng. A scholar is included among the top collaborators of Eileen Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Teng. Eileen Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lau, Wen Min, Eileen Teng, Kie Kyon Huang, et al.. (2021). Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3 beta. 1 indexed citations
2.
Lau, Wen Min, Eileen Teng, Kie Kyon Huang, et al.. (2017). Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β. Molecular Cancer Therapeutics. 17(1). 232–242. 43 indexed citations
3.
Lau, Wen Min, Eileen Teng, Hui Shan Chong, et al.. (2014). CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells. Cancer Research. 74(9). 2630–2641. 171 indexed citations
4.
Teng, Eileen, Hui Shan Chong, Ting Ting Wang, et al.. (2010). Abstract 3371: Gastric cancer stem/initiating cells are enriched in the CD44 fraction of EpCAM expressing cells. Cancer Research. 70(8_Supplement). 3371–3371. 1 indexed citations
5.
Seet, Li‐Fong, et al.. (2008). Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum‐free conditions*. European Journal Of Haematology. 82(2). 124–132. 28 indexed citations
8.
Tan, Yee‐Joo, Eileen Teng, Shuo Shen, et al.. (2004). A Novel Severe Acute Respiratory Syndrome Coronavirus Protein, U274, Is Transported to the Cell Surface and Undergoes Endocytosis. Journal of Virology. 78(13). 6723–6734. 121 indexed citations
9.
Tan, Yee‐Joo, Eileen Teng, & Anthony E. Ting. (2003). A small inhibitor of the interaction between Bax and Bcl-X L can synergize with methylprednisolone to induce apoptosis in Bcl-X L -overexpressing breast-cancer cells. Journal of Cancer Research and Clinical Oncology. 129(8). 437–448. 9 indexed citations
10.
Beerheide, Walter, Yee‐Joo Tan, Eileen Teng, et al.. (2000). Downregulation of Proapoptotic Proteins Bax and Bcl-XS in p53 Overexpressing Hepatocellular Carcinomas. Biochemical and Biophysical Research Communications. 273(1). 54–61. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026